Landscapes / Targets
CEACAM5
12 drugs act on CEACAM5, in 15 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs12
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Artificial immunoglobulin |
Phase 3 | 23 Dec 2027Phase 1/2 trial completes | |||
| How it works | An antibody | ||||
| Next date | 23 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Colorectal Cancer, Solid Tumors and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 2 | 21 May 2028Phase 2 trial completes | |||
| Next date | 21 May 2028 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Solid Tumor Cancer | ||||
| Open drug page | |||||
— |
CSPC · Public 1093.HK |
Phase 1/2 | 1 May 2029Phase 1/2 trial completes | ||
| Next date | 1 May 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Gastric Cancer (GC) and 2 more | ||||
| Open drug page | |||||
— |
Bristol Myers Squibb · Public BMY |
Phase 1/2 | — | ||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
NEO-201not checked |
— |
Phase 1/2 | — | ||
| Also tested for | Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 23 Jul 2028Phase 1 trial completes | |||
| Next date | 23 Jul 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2028Phase 1 trial completes | |||
| Next date | 31 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor (Phase I), RAS Mutation | ||||
| Open drug page | |||||
— |
Pfizer · Public PFE |
Phase 1 | 12 Sep 2029Phase 1 trial completes | ||
| Next date | 12 Sep 2029 · Phase 1 trial completes | ||||
| Also tested for | Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung and 4 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 11 of 12 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026